RSS Feed Print
FDA approves THC trial for Alzheimer's disease
Lane Simonian
Posted: Wednesday, August 12, 2020 10:49 AM
Joined: 12/12/2011
Posts: 4837


The FDA just approved a trial using low doses of THC, melatonin, and turmeric for the potential treatment of Alzheimer's disease.  The THC will come from hemp oil and is less than the .3 percent federal limit.  That makes this trial possible.

https://www.proactiveinvestors.com/companies/news/217342/india-globalization-capital-stock-pops-after-cbd-based-hyalolex-drops-for-alzheimers-patients-launches-in-puerto-rico-217342.html

https://www.marketscreener.com/INDIA-GLOBALIZATION-CAPIT-57355601/news/India-Globalization-Capital-FDA-Approves-Initiation-of-IGC-s-Cannabinoid-Trial-on-Alzheimer-s-Pati-31101625/

The main focus in this trial is in improving behavioral and psychological symptoms of dementia.  A small, past trial for THC in Israel suggests this may be a good target:

https://pubmed.ncbi.nlm.nih.gov/26757043/

Turmeric/curcumin and melatonin have long been suggested as treatments for Alzheimer's disease because of their antioxidant properties, but have not seemed too effective so far.

This will be a good test to see the effects of THC (combined with turmeric and melatonin) on people with dementia.


Rfloyd
Posted: Tuesday, September 8, 2020 9:27 AM
Joined: 9/8/2020
Posts: 1


Finally the USA is far behind other countries in research due to pot past classification .